Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Mirjam Fässler, Stefan Diem, Joanna Mangana, Omar Hasan Ali, Fiamma Berner, David Bomze, Sandra Ring, Rebekka Niederer, Cristina Gil Cruz, Christian Perez Shibayama, Michal Krolik, Marco Siano, Markus Joerger, Mike Recher, Lorenz Risch, Sabine Güsewell, Martin Risch, Daniel E Speiser, Burkhard Ludewig, Mitchell P Levesque, Reinhard Dummer & Lukas Flatz
abstract |
BACKGROUND METHODS RESULTS CONCLUSIONS Ethikkommission Ostschweiz, EKOS 16/079 https://ongoingprojects.swissethics.ch/runningProjects_list. php?q=%28BASECID~contains~2016-00998%29&orderby=dBASECID . |
citation | Fässler M, Diem S, Mangana J, Hasan Ali O, Berner F, Bomze D, Ring S, Niederer R, Gil Cruz C, Perez Shibayama C, Krolik M, Siano M, Joerger M, Recher M, Risch L, Güsewell S, Risch M, Speiser D E, Ludewig B, Levesque M P, Dummer R, Flatz L. Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. J Immunother Cancer 2019; 7:50. |
type | journal paper/review (English) |
date of publishing | 20-02-2019 |
journal title | J Immunother Cancer (7/1) |
ISSN electronic | 2051-1426 |
pages | 50 |
PubMed | 30786924 |
DOI | 10.1186/s40425-019-0523-2 |